MORE►
heart disease
HeartSciences' MyoVista Wavelet ECG. [Photo: HeartSciences]
HeartSciences Pumps Life into Assessing Diastolic Dysfunction with New AI Patent
by Lance Murray | Sep 22, 2022
Southlake-based HeartSciences, which closed on a $6.375M IPO in June, applies AI-based technology to an ECG to detect cardiac dysfunction—one of the earliest signs of heart disease. The company says this can't be diagnosed by current conventional ECGs, making its MyoVista Wavelet ECG device a potential game changer.
CEO Andrew Simpson says adding this diagnostic information to an ECG "addresses a significant unmet need in the market with an estimated 100 million-plus ECG tests performed annually in the U.S.A. alone."
by Lance Murray |
Nov 15, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also find news on UTSW and the American Heart Association examining cardiac concerns, as well as Cook Children’s in Fort Worth receiving a grant to bolster research.
MORE►
by Lance Murray |
Jun 29, 2018
Also, a collaborative study looks at how important exercise is to good health for those diagnosed with depression. Here are some of the research projects underway in North Texas aimed at making our lives better.
MORE►
by Lance Murray |
May 23, 2016
Coronary microvascular dysfunction is a disease that affects the walls and inner linings of tiny coronary artery blood vessels that branch off from larger coronary arteries.
MORE►
